Cargando…

Comparison of questionnaire responses regarding awareness of Japanese Society of Hypertension guidelines for the management of hypertension between 2014 and 2019 in primary care

In 2019, the Japanese Society of Hypertension guidelines for the management of hypertension (JSH) were revised. We previously reported the awareness of JSH among general practitioners in 2014, and in the current study, the same questionnaire was administered to determine their awareness of JSH 2019,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobayashi, Kazuo, Hatori, Nobuo, Sakai, Hiroyuki, Furuki, Takayuki, Miyakawa, Masaaki, Tamura, Kouichi, Sato, Kazuyoshi, Kanamori, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273028/ https://www.ncbi.nlm.nih.gov/pubmed/34253880 http://dx.doi.org/10.1038/s41440-021-00693-3

Ejemplares similares

Polypharmacy influences the renal composite outcome in patients treated with sodium‐glucose cotransporter 2 inhibitors
por: Kobayashi, Kazuo, et al.
Publicado: (2022)

Sodium–glucose cotransporter 2 inhibitor‐induced reduction in the mean arterial pressure improved renal composite outcomes in type 2 diabetes mellitus patients with chronic kidney disease: A propensity score‐matched model analysis in Japan
por: Kobayashi, Kazuo, et al.
Publicado: (2021)

The Comparison of the Kidney Effects of Dipeptidyl Peptidase 4 Inhibitors and Glucagon-Like Peptide 1 Agonist-Administered Concomitant with Sodium-Glucose Cotransporter 2 Inhibitors in Japanese Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
por: Kobayashi, Kazuo, et al.
Publicado: (2021)

Comparison of the blood pressure management between sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists
por: Kobayashi, Kazuo, et al.
Publicado: (2022)

Concomitant treatment with insulin and sodium–glucose cotransporter 2 inhibitors was associated with the renal composite outcome in Japanese patients with type 2 diabetes and chronic kidney disease: A propensity score‐matched analysis
por: Toyoda, Masao, et al.
Publicado: (2022)

The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonists
por: Kobayashi, Kazuo, et al.
Publicado: (2023)

Primary Care-Based Investigation of the Effect of Sitagliptin on Blood Pressure in Hypertensive Patients With Type 2 Diabetes
por: Yuasa, Shouhei, et al.
Publicado: (2017)

Blood pressure after treatment with sodium–glucose cotransporter 2 inhibitors influences renal composite outcome: Analysis using propensity score‐matched models
por: Kobayashi, Kazuo, et al.
Publicado: (2020)

Hypertension doctors’ awareness and practice of medication adherence in hypertensive patients: a questionnaire-based survey
por: Liu, Tao, et al.
Publicado: (2023)

South African hypertension practice guideline 2014
por: Seedat, YK, et al.
Publicado: (2014)

Key Points of the 2019 Japanese Society of Hypertension Guidelines for the Management of Hypertension
por: Kario, Kazuomi
Publicado: (2019)

Relation between Blood Pressure Management and Renal Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Kidney Disease
por: Kobayashi, Kazuo, et al.
Publicado: (2019)

Awareness of hypertension guidelines and the diagnosis and evaluation of hypertension by primary care physicians in Nigeria
por: Ale, OK, et al.
Publicado: (2017)

Meta-analysis on the Therapeutic State of Hypertensive Population in Japan: Focusing on the Impact of New Diagnostic Criteria of Japanese Guideline for the Management of Hypertension 2000
por: Hasegawa, Toshihiko, et al.
Publicado: (2007)

The Effect of ‘Integrated Health Promotion Initiative’ on Awareness among Opinion Leaders Regarding Hypertension
por: Dongre, AR, et al.
Publicado: (2008)

Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19
por: Shibata, Shigeru, et al.
Publicado: (2020)

Influence of stress induced by the first announced state of emergency due to coronavirus disease 2019 on outpatient blood pressure management in Japan
por: Kobayashi, Kazuo, et al.
Publicado: (2021)

Impact of the first announced state of emergency owing to coronavirus disease 2019 on stress and blood pressure levels among patients with type 2 diabetes mellitus in Japan
por: Ito, Shun, et al.
Publicado: (2022)

Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: 2014 updates
por: Idrees, Majdy M., et al.
Publicado: (2014)

Awareness, Attitudes, and Concerns Regarding Heated Tobacco Products Among Physicians in Japan
por: Otsuka, Yuichiro, et al.
Publicado: (2023)

Symptom‐based portopulmonary hypertension screening questionnaire in Japanese patients with chronic liver disease
por: Wakabayashi, Shun‐Ichi, et al.
Publicado: (2023)

Awareness regarding clinical application of pharmacogenetics among Japanese pharmacists
por: Obara, Taku, et al.
Publicado: (2015)

Knowledge, attitude and practice of Iranian hypertensive patients regarding hypertension
por: Rashidi, Yaseen, et al.
Publicado: (2018)

Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
por: Watanabe, Toshiaki, et al.
Publicado: (2015)

Awareness of hypertension and factors associated with uncontrolled hypertension in Sudanese adults
por: Babiker, Fawzi A, et al.
Publicado: (2013)

Impact of the COVID-19 pandemic on physical and psychological activities in elderly patients with hypertension
por: Azushima, Kengo, et al.
Publicado: (2022)

Erratum: Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: 2014 updates
Publicado: (2017)

Pharmaceutical company payments to authors of the Japanese guidelines for the management of hypertension
por: Senoo, Yuki, et al.
Publicado: (2021)

Effects of sodium-glucose cotransporter 2 inhibitors on urinary excretion of intact and total angiotensinogen in patients with type 2 diabetes
por: Yoshimoto, Takuo, et al.
Publicado: (2017)

Hypertension: empirical evidence and implications in 2014
por: Makridakis, Spyros, et al.
Publicado: (2014)

The Proportion of Long-term Response to Anti-N IgG Antibody after 12 Months for COVID-19 Subclinical Infections and a Longitudinal Survey for COVID-19 Subclinical Infections in 2021
por: Matsuba, Ikuro, et al.
Publicado: (2022)

The Prevalence and Awareness of Hypertension and the Relationship between Hypertension and Snoring in the Korean Population
por: Kim, Jin Seok, et al.
Publicado: (2001)

Awareness and control of hypertension in Bangladesh: follow-up of a hypertensive cohort
por: Alam, Dewan Shamsul, et al.
Publicado: (2014)

Quality of Life and Awareness of Hypertension Among Hypertensive Patients in Saudi Arabia
por: Alshammari, Sulaiman A, et al.
Publicado: (2021)

Prevalence, awareness, treatment and control of hypertension and sodium intake in Jiangsu Province, China: a baseline study in 2014
por: Yongqing, Zhang, et al.
Publicado: (2016)

Prevalence, Awareness and Control of Hypertension in Uganda
por: Musinguzi, Geofrey, et al.
Publicado: (2013)

Prevalence of pre-hypertension and hypertension, awareness, treatment, and control of hypertension, and cardiovascular risk factors in postmenopausal women
por: Eghbali-Babadi, Maryam, et al.
Publicado: (2021)

Knowledge, Awareness and Self-Care Practices of Hypertension among Cardiac Hypertensive Patients
por: Bilal, Muhammad, et al.
Publicado: (2016)

Hypertension Control Cascade: A Framework to Improve Hypertension Awareness, Treatment, and Control
por: Wozniak, Gregory, et al.
Publicado: (2015)

Psychometric Validation of a Japanese Version of the emPHasis-10 Questionnaire, a Patient-Reported Outcome Measure for Pulmonary Hypertension　― Multicenter Study in Japan ―
por: Takeyasu, Rika, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8gt6oqmup4biq8lu1bhlemqptp